Intrauterine programming of reproductive function - A valid concept?;Intrauterine programmierung reproduktiver funktionen - Ein tragfähiges konzept?

Gynakologisch-geburtshilfliche Rundschau

Volumn 49, Issue 1, 2009, Pages 2-7

  Schleussner, Ekkehard ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Androgen excess; Fetal programming; Polycystic ovary syndrome; Puberty; Reproductive function

Indexed keywords

ANDROGEN; FOLLITROPIN; LUTEINIZING HORMONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANOVULATION; CARDIOVASCULAR FUNCTION; FEEDBACK SYSTEM; GONAD FUNCTION; HUMAN; HYPERANDROGENISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INTRAUTERINE GROWTH RETARDATION; MENARCHE; METABOLIC REGULATION; NEUROENDOCRINE SYSTEM; OVARY POLYCYSTIC DISEASE; POSTNATAL GROWTH; PRECOCIOUS PUBERTY; PRENATAL EXPOSURE; PUBERTY; REPRODUCTION; REVIEW; SEXUAL MATURATION; SMALL FOR DATE INFANT; VIRILIZATION;

ANIMALS; BODY PATTERNING; FETAL DEVELOPMENT; HUMANS; REPRODUCTION; VISCERA;

EID: 60249093022     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184440     Document Type: Review

References (47)

1. Barker DJP: In utero programming of chronic disease. Clin Sci 1998;95:115-128.
2. Dörner G: Hormones and Brain Differentiation. Amsterdam, Elsevier, 1976.
3. Dörner G, Götz F, Rohde W, Plagemann A, Lindner R, Peters H, Ghanaati Z: Genetic and epigenetic effects on sexual brain organization mediated by sex hormones. Neuroendocrinol Lett 2001;22:403-409.
4. Gluckman PD, Hansons MA: Evolution, development and timing of puberty. Trends Endocrinol Metab 2006;17:7-12.
5. Schleussner E: Die Pubertät und ihre Störungen; in Beller F (Hrsg): Brevier des Frauenarztes Band 1. Hofstetten, Pro Verlag, 2000, pp 39-78.
6. Hokken-Koelega ACS: Timing of puberty and fetal growth. Best Pract Clin Endocrinol Metab 2002;16:65-71.
7. Adair LS: Size at birth predicts age at menarche. Pediatrics 2001;107:E59.
8. Bhargava SK, Ramji S, Srivastava U, et al: Growth and sexual maturation of low birth weight children: a 14 year follow up. Indian Pediatr 1995;32:963-970.
9. Persson I, Ahlsson F, Ewald U, Tuvemo T, Qingyuan M, von Rosen D, Proos L: Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long term diseases. Am J Epidemiol 1999;150:747-755.
10. Jaquet D, Leger J, Chevenne D, Czernichow P, Levy-Marchal C: Intrauterine growth retardation predisposes to insulin resistence but not to hyperandrogenism in young women. J Clin Endocrinol Metab 1999;84:3945-3949.
11. Koziel S, Jankowska EA: Effect of low versus normal birth weight on menarche in 14-year-old Polish girls. J Paediatr Child Health 2002;38:268-271.
12. Berankova H: Maturation and fertility in women with low birth weights. Cas Lek Cesk 1997;136:413-415.
13. Fledelius HC: Inhibited growth and development as permanent features of low birth weight: a longitudinal study of eye size, height, head circumference, interpupillary distance and exophthalmometry, as measured at the age of 10 and 18 years. Acta Paediatr Scand 1982;71:645-650.
14. Lumey LH, Stein AD: In utero exposure to famine and subsequent fertility: the Dutch Famine Birth Cohort Study. Am J Public Health 1997;87:1962-1966.
15. Mittelbach D: Zeitpunkt des Menarcheeintritts in Abhängigkeit vom körperlichen Entwicklungsstand und ausgewählten sozialen Faktoren. Dissertationsschrift, Universitätsbibliothek Jena, 2006.
16. Voigt M, Schneider KTM, Jährig K: Analyse des Geburtengutes des Jahrgangs 1992 der Bundesrepublik Deutschland. Teil 1: Neue Perzentilwerte für die Körpermasse von Neu geborenen. Geburts Frauenheilk 1996;10:16-24.
17. Sloboda DM, Hart R, Doherty D, Penell CE, Hickey M: Age at menarche: influences of prenatal and postnatal growth. J Clin Endocrinol Metab 2007;92:46-50.
18. Michels KB, Xue F: Role of birth weight in the etiology of breast cancer. Int J Cancer 2006;119:2007-2025.
19. Lienhardt A, Carel JC, Preux PM, Coutant R, Chaussain JL: Amplitude of pubertal growth in short stature children with intrauterine growth retardation. Horm Res 2002;57:88-94.
20. Vicens-Calvet E, Espadero RM, Carrascosa A, Spanish SGA Collaborative Group: Small for gestational age longitudinal study of the pubertal growth spurt in children born small for gestational age without postnatal catch-up growth. J Pediatr Endocrinol Metab 2002;15:381-388.
21. Lazar L, Pollak U, Kalter-Leibovici O, Pertzelan A, Phillip M: Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA). Eur J Endocrinol 2003;149:425-432.
22. deBruin JP, Dorland M, Bruinse HW, Spliet W, Nikkels PGJ, Te Velde ER: Fetal growth retardation as a cause of impaired ovarian development. Early Hum Dev 1998;51:39-46.
23. Cicognani A, Alessandroni R, Pasini A, Pirazzoli P, Cassio A, Barbieri E, Cacciari E: Low birth weight for gestational age and subsequent male gonadal function. J Pediatr 2002;141:376-379.
24. Ibanez L, Valls C, Potau N, Marcos MV, de Zegher F: Polycystic ovary syndrome after precocious pubarche: ontogeny of the low birthweight effect. Clin Endocrinol (Oxf) 2001;55:667-672.
25. Ibanez L, Potau N, Ferrer A, Rodriguez-Hierro F, Marcos MV, de Zegher F: Reduced ovulation rate in adolescent girls born small for gestational age. J Clin Endocrinol Metab 2002;87:3391-3393.
26. Ibanez L, Potau N, de Zegher F: Ovarian hyporesponsiveness to follicle stimulating hormone in adolescent girls born small for gestational age. J Clin Endocrinol Metab 2000;85:2624-2626.
27. Ibanez L, Potau N, Enriquez G, de Zegher F: Reduced uterine and ovarian size in adolescent girls born small for gestational age. Pediatr Res 2000;47:575-577.
28. Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M, Carrascosa A, Vicens-Calvet E: Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993;76:1599-1603.
29. Ibanez L, Potau N, Enríquez G, Marcos MV, de Zegher F: Hypergonadotropinemia with reduced uterine and ovarian size in women born small-for-gestational-age. Hum Reprod 2003;18:1565-1569.
30. Franks S: Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
31. Robinson JE, Forsdike RA, Taylor JA: In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone. Endocrinology 1999;140:5797-5805.
32. Abbott DH, Barnett DK, Bruns CM, Dumesic DA: Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005;11:357-374.
33. Eisner JR, Dumesic DA, Kemnitz JW, Abbott DH: Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 2000;85:1206-1210.
34. Dumesic DA, Abbott DH, Eisner JR, Goy RW: Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. Fertil Steril 1997;67:155-163.
35. Steckler T, Wang J, Bartol F, Roy SK, Padmanabhan V: Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increase ovarian follicular recruitment. Endocrinology 2005;146:3185-3193.
36. MacLaughlin DT, Donahoe PK: Sex determination and differentiation. N Engl J Med 2004;350:367-378.
37. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM: Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994;79:1328-1333.
38. Völkl T, Simm D, Beier Ch, Dörr HG: Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 2006;117:98-105.
39. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE: Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002;17:2573-2579.
40. Xita N, Tsatsoulis A: Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical and genetic association studies. J Clin Endocrinol Metab 2006;91:1660-1666.
41. Thoumsin HJ, Alsat E, Cedard L: In vitro aromatization of androgens into estrogens in placental insufficiency. Gynecol Obstet Invest 1982;13:37-43.
42. Cresswell J, Barker DJ, Osmond C, Egger P, Phillips DIW, Fraser RB: Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 1997;150:1131-1135.
43. Sadrzadeh S, Klip WA, Broekmans FJ, Schats R, Willemsen WN, Burger CW, Van Leeuwen FE, Lambalk CB, OMEGA Project group: Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort. Hum Reprod 2003;18:2225-2230.
44. Pandolfi C, Zugaro A, Lattanzio F, Necozione A, Barbonetti A, Colangeli MS, et al: Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome. Metabolism Clin Exp 2008;57:999-1004.
45. deZegher F, Ibanez L: Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome. Fertil Steril 2006;86:S4-S5.
46. Hogeveen KN, Cousin P, Pugeat M, Dewailly D, Soudan B, Hammond GL: Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J Clin Invest 2002;109:973-981.
47. Ibanez L, Ong K, Valls C, Marcos MV, Dunger DB, de Zegher F: Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006;91:2888-2891.